The Effect of Any Willing Provider and Freedom of Choice Laws on Prescription Drug Expenditures
University of Pennsylvania Law School; Erasmus School of Law; PERC - Property and Environment Research Center
Joshua D. Wright
Federal Trade Commission; George Mason University School of Law
February 24, 2014
U of Penn, Inst for Law & Econ Research Paper No. 12-39
Any Willing Provider and Freedom of Choice laws restrict the ability of managed care entities, including pharmacy benefit managers, to selectively contract with providers. The managed care entities argue this limits their ability to generate cost savings, while proponents of the laws suggest that such selective contracts limit competition, leading to an increase in aggregate costs. We examine the effect of state adoption of such laws on prescription drug expenditures, finding that any willing provider/freedom of choice laws are associated with cost increases of at least 3 percent. These results suggest that these laws are harmful from a spending perspective.
Number of Pages in PDF File: 24
Keywords: managed care, pharmacy benefit managers, spending, selective contracting
JEL Classification: I18, K32, L42working papers series
Date posted: December 1, 2012 ; Last revised: February 26, 2014
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo7 in 0.610 seconds